Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (695)	6/9/1999 4:47:00 PM
From: scaram(o)uche	Read Replies (2) of 4974

Pfizer seems to have a few problems with potential toxicities. Here's the latest......... biz.yahoo.com I think I know why they have so many problems. Companies take on personalities based on the type of person that they retain long-term. If you watch long enough, you can "feel" the culture from outside. It's unrelated, but perhaps they should increase their scientist:attorney ratio? Celexa sure is looking like an attractive alternative to Prozac, for those patients who might have reimbursement issues.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next